Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
$0.15
$0.23
$5.50
$258K2.57122,366 shsN/A
Nuvectra Corp stock logo
NVTRQ
Nuvectra
$0.02
-25.0%
$0.02
$0.01
$4.30
N/AN/AN/A382,600 shs
OCLG
Oncologix Tech
$0.00
$0.00
$0.00
$0.00
N/A1.6132,755 shsN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
$0.02
$0.02
$0.01
$4.28
N/AN/AN/AN/A
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
0.00%0.00%0.00%0.00%0.00%
Presbia PLC stock logo
LENS
Presbia
0.00%0.00%0.00%0.00%0.00%
Nuvectra Corp stock logo
NVTRQ
Nuvectra
0.00%0.00%0.00%0.00%0.00%
OCLG
Oncologix Tech
0.00%0.00%0.00%+100.00%-75.00%
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
N/AN/AN/AN/AN/AN/AN/AN/A
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/AN/AN/AN/AN/AN/AN/AN/A
OCLG
Oncologix Tech
N/AN/AN/AN/AN/AN/AN/AN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/AN/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
N/AN/AN/AN/A
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/AN/AN/AN/A
OCLG
Oncologix Tech
N/AN/AN/AN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/AN/AN/AN/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
$20K0.00N/AN/A$0.09 per share0.00
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/AN/AN/AN/AN/AN/A
OCLG
Oncologix Tech
N/AN/AN/AN/AN/AN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
-$8.41MN/A0.00N/AN/A-36,604.35%-414.02%-195.56%N/A
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/AN/A0.00N/AN/AN/AN/AN/A
OCLG
Oncologix Tech
N/AN/A0.00N/AN/AN/AN/AN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/AN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/AN/AN/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
N/AN/AN/AN/AN/A
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/AN/AN/AN/AN/A
OCLG
Oncologix Tech
N/AN/AN/AN/AN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
1.24
2.88
2.82
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/AN/AN/A
OCLG
Oncologix Tech
N/AN/AN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/A
Presbia PLC stock logo
LENS
Presbia
16.42%
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/A
OCLG
Oncologix Tech
N/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/A

Insider Ownership

CompanyInsider Ownership
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/A
Presbia PLC stock logo
LENS
Presbia
74.20%
Nuvectra Corp stock logo
NVTRQ
Nuvectra
2.90%
OCLG
Oncologix Tech
39.90%
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
1.02%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
113N/AN/ANot Optionable
Presbia PLC stock logo
LENS
Presbia
2417.23 millionN/ANot Optionable
Nuvectra Corp stock logo
NVTRQ
Nuvectra
197N/AN/ANot Optionable
OCLG
Oncologix Tech
191N/AN/ANot Optionable
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
125N/AN/ANot Optionable

LENS, VLRXQ, NVTRQ, EVARF, and OCLG Headlines

Recent News About These Companies

Valeritas Holdings Inc (VLRXQ)

Company Descriptions

Lombard Medical logo

Lombard Medical

OTCMKTS:EVARF
Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company's principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees. Its products also include Altura endovascular stent graft system for the treatment of standard AAA anatomies; Aorflex delivery system for accurate placement of Aorfix in the abdominal aorta; and IntelliFlex LP delivery system that enhances the precision and control of Aorfix deployment and placement. Lombard Medical, Inc. sells its products directly through its direct sales force and distributors to state-or-government-owned hospitals. The company was founded in 2000 and is headquartered in Didcot, the United Kingdom.
Presbia logo

Presbia

NASDAQ:LENS
Presbia PLC is a holding company. It engages in the development and marketing of presbyopia-correcting solutions under the trademark of Presbia Flexivue Microlens. It operates through the Restoration of Clear Vision Caused by Presbyopia segment. The company was founded on February 2, 2014 and is headquartered in Dublin, Ireland.
Nuvectra logo

Nuvectra

OTCMKTS:NVTRQ
Nuvectra Corporation, a neurostimulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets. The company offers Algovita, a spinal cord stimulation system for the treatment of chronic intractable pain of the trunk and limbs. It is also developing Virtis, a sacral neuromodulation (SNM) system for the treatment of chronic urinary retention and overactive bladder; and technologies to support other indications, including SNM for the treatment of overactive bladder and deep brain stimulation to treat Parkinson's disease. The company serves hospitals, surgery centers, and medical facilities through a direct sales force and third-party distributors in the United States and Europe. Nuvectra Corporation was founded in 2008 and is headquartered in Plano, Texas.

Oncologix Tech

OTCMKTS:OCLG
Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. It offers personal home care services, including daily living assistance, companionship, and homemaker services, as well as Alzheimer's care, home care resource planning, and medical care coordination services. The company also manufactures, markets, and distributes medical technologies and products for skilled nursing facilities, acute and critical care facilities, assisted living facilities, hospitals and medical institutions, federal agencies, home medical care industry, respiratory and therapy- physical/occupational therapy centers. In addition, it distributes and sells home medical equipment for sleep and respiratory therapies; supplies and services durable medical equipment to treat obstructive Sleep Apnea; C-PAP and BiPAP oxygen equipment, a large selection of mask interfaces; and offers personalized treatment plans, as well as monitoring and support services. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana.
Valeritas logo

Valeritas

OTCMKTS:VLRXQ
Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.